Liyi Zou

687 total citations
25 papers, 538 citations indexed

About

Liyi Zou is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Liyi Zou has authored 25 papers receiving a total of 538 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 5 papers in Cancer Research and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Liyi Zou's work include Bone Metabolism and Diseases (4 papers), Genomics, phytochemicals, and oxidative stress (3 papers) and Cancer-related molecular mechanisms research (3 papers). Liyi Zou is often cited by papers focused on Bone Metabolism and Diseases (4 papers), Genomics, phytochemicals, and oxidative stress (3 papers) and Cancer-related molecular mechanisms research (3 papers). Liyi Zou collaborates with scholars based in China, Hong Kong and Macao. Liyi Zou's co-authors include Tie Wu, Shaoru Chen, Li Li, Sien Lin, Gang Li, Cui Liao, Li Li, Jikun Du, Li Li and Yanhua Yang and has published in prestigious journals such as PLoS ONE, Biomaterials and Frontiers in Pharmacology.

In The Last Decade

Liyi Zou

23 papers receiving 530 citations

Peers

Liyi Zou
Dezhi Zhang China
Jinfu Lu China
Nian Chen China
Wonseok Lee South Korea
Masum M. Mia Singapore
Li‐Yen Shiu Taiwan
Yingbo Zhang China
Zhipeng Li China
Lei Zong China
Dezhi Zhang China
Liyi Zou
Citations per year, relative to Liyi Zou Liyi Zou (= 1×) peers Dezhi Zhang

Countries citing papers authored by Liyi Zou

Since Specialization
Citations

This map shows the geographic impact of Liyi Zou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Liyi Zou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Liyi Zou more than expected).

Fields of papers citing papers by Liyi Zou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Liyi Zou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Liyi Zou. The network helps show where Liyi Zou may publish in the future.

Co-authorship network of co-authors of Liyi Zou

This figure shows the co-authorship network connecting the top 25 collaborators of Liyi Zou. A scholar is included among the top collaborators of Liyi Zou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Liyi Zou. Liyi Zou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zou, Liyi, Cui Yang, Weijing Liu, et al.. (2025). Downregulation of SLC7A11 by Bis(4‐Hydroxy‐3,5‐Dimethylphenyl) Sulfone Induces Ferroptosis in Hepatocellular Carcinoma Cell. Molecular Carcinogenesis. 64(3). 580–596. 1 indexed citations
2.
Yang, Guangli, Lijun Yan, Wen Zheng, et al.. (2025). Phillyrin for sepsis-related acute lung injury: A potential strategy suppressing GSK-3β. Molecular Immunology. 183. 115–136. 1 indexed citations
3.
Zou, Liyi, Xiaodan Li, Jie Lin, et al.. (2024). Ethyl 2,2-difluoro-2-(2-oxo-2H-chromen-3-yl) acetate attenuates the malignant biological behaviors of non-small cell lung cancer via suppressing EGFR/PI3K/AKT/mTOR signaling pathway. Journal of Pharmacy and Pharmacology. 76(3). 269–282. 1 indexed citations
4.
Zou, Liyi, et al.. (2024). SLC40A1 in iron metabolism, ferroptosis, and disease: A review. PubMed. 16(4). e1644–e1644. 10 indexed citations
5.
Yan, Lijun, Xiangjun Zhou, Guangli Yang, et al.. (2023). Liang-Ge-San: a classic traditional Chinese medicine formula, attenuates acute inflammation via targeting GSK3β. Frontiers in Pharmacology. 14. 1181319–1181319. 1 indexed citations
6.
Jiang, Xiaoqian, Liu Y, Xuelan Zeng, et al.. (2023). 粤港澳大湾区深度减排路径和金融支持转型机遇. 1 indexed citations
7.
Wu, Kefeng, Zhongqin Gong, Liyi Zou, et al.. (2019). Sargassum integerrimum inhibits oestrogen deficiency and hyperlipidaemia-induced bone loss by upregulating nuclear factor (erythroid-derived 2)-like 2 in female rats. Journal of Orthopaedic Translation. 19. 106–117. 11 indexed citations
8.
Xu, Bilian, et al.. (2018). Ginsenoside Rb1 does not halt osteoporotic bone loss in ovariectomized rats. PLoS ONE. 13(9). e0202885–e0202885. 17 indexed citations
9.
Lin, Sien, Cui Liao, Guanghua Chen, et al.. (2018). PLGA/β-TCP composite scaffold incorporating salvianolic acid B promotes bone fusion by angiogenesis and osteogenesis in a rat spinal fusion model. Biomaterials. 196. 109–121. 85 indexed citations
10.
Zou, Liyi, Shaoru Chen, Li Li, & Tie Wu. (2017). The protective effect of hyperoside on carbon tetrachloride-induced chronic liver fibrosis in mice via upregulation of Nrf2. Experimental and Toxicologic Pathology. 69(7). 451–460. 42 indexed citations
11.
Lu, Jiaqi, et al.. (2017). Effect of prednisone treatment for 30 and 90 days on bone metabolism in collagen-induced arthritis (CIA) rats. Journal of Bone and Mineral Metabolism. 36(6). 628–639. 8 indexed citations
12.
Zou, Liyi, Jin Li, Bilian Xu, et al.. (2017). Salvianolic acid B and danshensu induce osteogenic differentiation of rat bone marrow stromal stem cells by upregulating the nitric oxide pathway. Experimental and Therapeutic Medicine. 14(4). 2779–2788. 11 indexed citations
13.
14.
Chen, Yuanfeng, Sien Lin, Yuxin Sun, et al.. (2016). Translational potential of ginsenoside Rb1 in managing progression of osteoarthritis. Journal of Orthopaedic Translation. 6. 27–33. 23 indexed citations
15.
Zou, Liyi, et al.. (2016). Lrrc75b is a novel negative regulator of C2C12 myogenic differentiation. International Journal of Molecular Medicine. 38(5). 1411–1418. 5 indexed citations
16.
17.
Li, Li, Jikun Du, Yun Zhang, et al.. (2015). Protective Effects of Coenzyme Q10 Against Hydrogen Peroxide-Induced Oxidative Stress in PC12 Cell: The Role of Nrf2 and Antioxidant Enzymes. Cellular and Molecular Neurobiology. 36(1). 103–111. 40 indexed citations
18.
Lin, Sien, Jianping Huang, Zheng Liang, et al.. (2014). Glucocorticoid-Induced Osteoporosis in Growing Rats. Calcified Tissue International. 95(4). 362–373. 42 indexed citations
19.
Chen, Shaoru, Liyi Zou, Li Li, & Tie Wu. (2013). The Protective Effect of Glycyrrhetinic Acid on Carbon Tetrachloride-Induced Chronic Liver Fibrosis in Mice via Upregulation of Nrf2. PLoS ONE. 8(1). e53662–e53662. 136 indexed citations
20.
Zhang, Zhiping, Tingting You, Liyi Zou, et al.. (2008). [Effect of a compound Danshen preparation in preventing long-term gastric lipid emulsion administration-induced nonalcoholic steatohepatitis in rats].. PubMed. 28(7). 1109–13. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Dezhi Zhang Breakdown of academic impact, for papers by Jinfu Lu Breakdown of academic impact, for papers by Nian Chen Breakdown of academic impact, for papers by Wonseok Lee Breakdown of academic impact, for papers by Masum M. Mia Breakdown of academic impact, for papers by Li‐Yen Shiu Breakdown of academic impact, for papers by Yingbo Zhang Breakdown of academic impact, for papers by Zhipeng Li Breakdown of academic impact, for papers by Lei Zong
Rankless by CCL
2026